Levonorgestrel, U.S.P. active pharmaceutical ingredient, packaged in 1 kg container, Rx only, Spe...

FDA Drug Recall #D-0882-2017 — Class II — April 13, 2017

Recall Summary

Recall Number D-0882-2017
Classification Class II — Moderate risk
Date Initiated April 13, 2017
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Spectrum Laboratory Products, Inc.
Location New Brunswick, NJ
Product Type Drugs
Quantity 1 container

Product Description

Levonorgestrel, U.S.P. active pharmaceutical ingredient, packaged in 1 kg container, Rx only, Spectrum Chemical Mfg. Corp, Gardena, CA 90248, New Brunswick, NJ 08901, Product code L1229.

Reason for Recall

CGMP Deviations: these repackaged and redistributed products are being recalled due to a recall notice from the active pharmaceutical ingredient manufacturer for deviations from current Good Manufacturing Practices that were found during a recent FDA inspection.

Distribution Pattern

Nationwide in the USA

Lot / Code Information

Lot #: 2FD0376, Exp 02/21/21

Other Recalls from Spectrum Laboratory Products, Inc.

Recall # Classification Product Date
D-0179-2023 Class I Epinephrine (L-Adrenaline), USP, CAS 51-43-4, 1... Dec 19, 2022
D-0180-2023 Class I Epinephrine (L-Adrenaline), USP, CAS 51-43-4, P... Dec 19, 2022
D-0881-2017 Class II Estradiol (17-B-Estradiol; Estra-1,3,5(10)-trie... Apr 13, 2017
D-1456-2016 Class II Zinc Acetate, Crystal, USP, packaged in 500 gra... Aug 1, 2016

Frequently Asked Questions

cGMP stands for Current Good Manufacturing Practice — the FDA's regulations governing drug manufacturing quality. A cGMP recall means the company failed to follow required manufacturing standards. This could involve inadequate testing, poor environmental controls, documentation failures, or process deviations. cGMP recalls do not always mean the product is directly harmful — in many cases, quality records are insufficient to confirm the product meets specifications. However, the FDA requires a recall because without proper documentation, product quality cannot be assured. These are often Class II or Class III recalls.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.